Suzette DiMascio, CHE, CMCE, CPC is President/CEO at CSI Specialty Group, a Globally Recognized Leadership Consulting & Talent Consulting that delivers consulting solutions and talent resources to help clients cultivate excellence through uniquely linking their business strategy to their people strategy for Specialty Pharmacy, Manufacturers, Mail Order/PBM & Health Systems & Healthplans Worldwide.
Darshan Kulkarni Pharm.D, Esq provides regulatory and legal advice to pharmacies and other FDA regulated entities and their service providers and focuses on the intersection of pharmacy and FDA related issues. He has worked as a pharmacist for more than 14 years in multiple capacities including hospitals, retail pharmacies, managed care, and has even participated as an unblinded clinician in clinical trials.
Brian Dickerson, Esq., is a partner at FisherBroyles LLP where he focuses his practice on complex litigation and regulatory matters defending pharmacy and healthcare clients against government actions, administrative proceedings and parallel civil and criminal proceedings. Mr. Dickerson litigates complex health care fraud, including anti-kickback, stark law and false claims cases throughout the U.S. related to Tricare, Department of Labor, Medicare and Medicaid, as well as pharmacy billing, pharmacy benefits manager disputes, and Foreign Corrupt Practices Act (FCPA) matters.
Badal Shah “Be the change you want to see in the world” by Mahatma Gandhi, has been the motto of Badal Shah’s life and his leadership. With several years of focused effort inside the pharmaceutical vertical, Badal Shah, B.Pharm, M.S. M.B.A., has transformed the approach to affecting successful outcomes inside the arena of thought leadership within health and life sciences.
Lisandra Robles is the President of the Latin Chapter of the APPA. She is a multifaceted buyer in a variety of recognized wholesalers in Puerto Rico for more than 17 years. Her experiences include managing purchases for generics, branded and over-the –counter drugs along with medical and surgical equipment and HHC.
Scott Freiman is the Business Development Director for BioProtein Technology, a national manufacturer and distributor of supplements and nutraceuticals, specializing in bio-identical growth factors. BioProtein Technology is a vertically integrated company, overseeing the entire process of their product line.
In addition, Scott is the owner of The Biz Dev Source, a sales and marketing supply and consulting company.
For nearly three decades, in different capacities, Scott has assisted independent pharmacies grow their bottom line by providing innovative front-end products, technical education and creative marketing programs.
Dr. Kenneth D. Lanier is a clinical pharmacist and founder of Praetorian Rx LLC. Dr. Lanier has extensive knowledge and experience with pharmacy business development, medication therapy management services, medication therapy management consulting services, and compounding consulting services. Deeply rooted in the community, Dr. Lanier has run many community service projects such as providing medication therapy management for NFL alumni, as well as continually developing his health care ministry, established in October 2014.
Nicolle McClure is a dedicated marketing individual, who has a passion for helping small business owners succeed. Over the last five years, Nicolle has been driven to help independent pharmacy owners survive and grow in an ever changing market, by offering a comprehensive marketing program tailored to their individual needs through GRX Marketing.
Jonathan Wright, Esq., In 2015, QPharma, Inc., a leading provider of compliance and commercial services to the life sciences industry, appointed Jonathan Wright, Esq., LL.M. to the position of General Counsel. Mr. Wright then assumed the role of Chief Legal Officer in 2016, overseeing the company’s legal matters, serving as a healthcare compliance expertise as a consultant to the firm’s roster of clients, and further serving QPharma as a strategic legal business advisor.
Alaa Elsaeed is a Management consultant at QuintilesIMS, one of the top specialized management consultancies on critical business issues in life sciences. He has 10+ years of experience in the Healthcare / Life sciences space, and currently advises leading Pharmaceutical and Biotechnology companies on Corporate, Commercial and Market access strategies.
Greg Moulthrop is the Chief Executive Officer (CEO) of InfiniTrak. His background includes extensive knowledge of economics, supply chain management and IT systems and has been working in the pharmaceutical & biotechnology industry for over a decade.
Shantel Houston is a fourth-year student at the University of South Florida College of Pharmacy. She serves as Class President, is an invited member of the Phi Lambda Sigma Pharmacy Leadership Society and the Rho Chi academic honor society and has held leadership positions in many organizations including the Kappa Epsilon Professional Pharmacy Fraternity.
Christopher von Zwehl is the Rx Security Specialist and Senior Vice President of Scripps Safe, Inc., a leader in pharmaceutical security and diversion control. Prior to Scripps, he was VP of Business Development at E-Renewables, LLC and VP of Sales at VARN International, the #1 global leader in printing products. Part time, Chris is currently the District Staff Officer for Marine Safety & Environmental Protection (DSO-MS) for the U.S. Coast Guard 7th District, Auxiliary.
Dr. Arlen Meyers is a professor emeritus of otolaryngology, dentistry, and engineering at the University of Colorado School of Medicine and the Colorado School of Public Health and President and CEO of the Society of Physician Entrepreneurs at www.sopenet.org. He consults for and speaks to companies, governments, colleges and universities around the world who need his expertise and contacts in the areas of bio entrepreneurship, bioscience, healthcare, healthcare IT, medical tourism -- nationally and internationally, new product development, product design, and financing new ventures.
Dr. Meyers is a former Harvard-Macy fellow and In 2010, he completed a Fulbright at Kings Business, the commercialization office of technology transfer at Kings College in London. Publications this year include "Building the Case for Biotechnology." "Optical Detection of Cancer", and " The Life Science Innovation Roadmap". Dr. Meyers is also an associate editor of the Journal of Commercial Biotechnology and Technology Transfer and Entrepreneurship and Editor-in-Chief of Medscape Reference: Otolaryngology-Head and Neck Surgery.
In addition, he is a faculty member at the University of Colorado Denver Graduate School and Direct the Program in Biomedical Entrepreneurship at the Jabs Center for Entrepreneurship at the University of Colorado Denver Business School and an iCorps participant and trainer
Dr. Meyers has been honored by Modern Healthcare as one of the 50 Most Influential Physician Executives of 2011 and nominated in 2012 and Best Doctors 2013.